BOLD, L'Oréal’s venture capital fund, invests in Timeline, a Swiss longevity biotech company

L’Oréal and Timeline today announced that L’Oréal’s strategic venture capital fund, BOLD, has acquired a minority stake in Timeline, a Swiss longevity biotech company. Timeline was founded in 2007 by Chris Rinsch (Co-Founder and President) and Patrick Aebischer (Co-Founder and Chairman) as a spin-off of the Swiss Federal Institute of Technology (EPFL) to develop innovative solutions for longevity in the food, beauty and health sectors. Timeline has developed a proprietary molecule, Mitopure®, that recycles and rejuvenates aging mitochondria, the powerhouses of cells. This breakthrough technology is backed by more than a decade of research by distinguished scientists, multiple gold standard clinical studies, and an unparalleled intellectual property portfolio. The investment will enable Timeline to further develop its unique technology and expand operations, while enabling future collaboration with L’Oréal.

“Longevity is about living healthier for longer and L’Oréal has been working for more than a decade to understand and anticipate what this could mean for beauty,” said Barbara Lavernos, Deputy Chief Executive Officer and in charge of Research, Innovation and Technology, L’Oréal Groupe. “Longevity adds a new dimension to beauty, focused on predicting, correcting and even reversing the ageing of our skin, scalp and hair. Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty.”

"This strategic collaboration reflects the breakthrough multidimensional approach that we've always believed is necessary to make meaningful advancements for longevity and healthspan," said Patrick Aebischer, Co-Founder and Chairman of Timeline. “I want to thank L’Oréal for its commitment to longevity solutions rooted in the highest level of science.”

About L’Oréal

For over 110 years, L’Oréal, the world’s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world. Our purpose, to create the beauty that moves the world, defines our approach to beauty as inclusive, ethical, generous and committed to social and environmental sustainability. With our broad portfolio of 37 international brands and ambitious sustainability commitments in our L’Oréal for the Future programme, we offer each and every person around the world the best in terms of quality, efficacy, safety, sincerity and responsibility, while celebrating beauty in its infinite plurality.

With 87 400 committed employees, a balanced geographical footprint and sales across all distribution networks (e-commerce, mass market, department stores, pharmacies, hair salons, branded and travel retail), in 2022 the Group generated sales amounting to 38.26 billion euros. With 20 research centers across 11 countries around the world and a dedicated Research and Innovation team of over 4 000 scientists and 5 500 tech and digital professionals, L’Oréal is focused on inventing the future of beauty and becoming a Beauty Tech powerhouse.

More information on https://www.loreal.com/en/mediaroom

About BOLD

BOLD, Business Opportunities for L’Oréal Development, is the global corporate venture capital fund of L’Oréal. Since its creation in 2018, BOLD has explored the frontier of beauty via strategic minority investments in promising startups across the beauty value chain. Its investment portfolio includes emerging brands as well as innovative companies in the domains of technology and biotechnology. For more information about BOLD, please visit: www.lorealboldventures.com

About Timeline

Timeline (parent company Amazentis) is a pioneering Swiss health science company committed to revolutionizing the longevity industry with its groundbreaking, clinically proven, proprietary ingredient Mitopure®. Offering a comprehensive approach to cellular health, Timeline incorporates the benefits of Mitopure inside its next generation nutritional supplements and topical skin health products. With more than a decade of expertise in aging science research, Timeline seeks to push the boundaries of human healthspan, contributing to a future where everyone can live longer, healthier lives. The company is backed by over 15 years of research by distinguished scientists, multiple clinical studies, over 50 patents and Nestlé Health Science has been an investor since 2019. For more information, please visit www.timelinenutrition.com